H1 Welcomes Former FDA Commissioner, Acquires Ribbon Health
Deal News | Jan 08, 2025 | Globenewswire
H1, a company dedicated to connecting the world with the right medical professionals, has made significant announcements including the appointment of former FDA Commissioner Dr. Stephen M. Hahn to their board, the acquisition of health data platform Ribbon Health, and unveiling its 2025 product roadmap. Dr. Hahn, renowned for his expertise in oncology and healthcare leadership, joins H1 as they aim to leverage their AI-driven platform for improved healthcare access. The acquisition of Ribbon Health enhances H1's capabilities, integrating comprehensive provider data to serve health plans and digital platforms. Additionally, H1 introduces a streamlined product suite targeting medical affairs, clinical trials, and commercial sectors. The company has drawn substantial backing from major investors, recognized for its achievements in diversity and innovation within the digital health space.
Sectors
- Healthcare Technology
- Pharmaceuticals & Biotechnology
- Digital Health
Geography
- United States – Both H1 and Ribbon Health operate within the U.S., and the article announces events related to the U.S. healthcare market.
Industry
- Healthcare Technology – This article involves companies that provide technology solutions to improve healthcare outcomes, such as H1 and Ribbon Health.
- Pharmaceuticals & Biotechnology – H1's products focus on clinical research, medical affairs, and commercial applications in the pharmaceutical sector.
- Digital Health – H1 and Ribbon Health work to integrate data-driven solutions within digital health platforms, improving healthcare delivery.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| H1 | Acquiring Company | Company | A company focused on connecting patients with the right healthcare professionals, leveraging data and AI. |
| Ribbon Health | Target Company | Company | A provider data platform that facilitates finding the right doctors across digital health platforms. |
| Dr. Stephen M. Hahn | New Board Member | Person | Former FDA Commissioner, appointed to H1's Board of Directors. |
| Ariel Katz | Co-founder and CEO of H1 | Person | CEO of H1, leading the company's mission to enhance healthcare connectivity. |
| Nate Maslak | Co-founder and CEO of Ribbon Health | Person | CEO of Ribbon Health, facilitating the company's acquisition by H1. |
| General Catalyst | Investor in Ribbon Health | Company | A venture capital firm that invested in Ribbon Health. |
| Andreessen Horowitz | Investor in Ribbon Health | Company | A venture capital firm (a16z) that invested in Ribbon Health. |
| BoxGroup | Investor in Ribbon Health | Company | A venture capital firm that invested in Ribbon Health. |
| Rock Health | Investor in Ribbon Health | Company | A venture capital firm that invested in Ribbon Health. |
| Sachin Jain | Investor in Ribbon Health | Person | Backed Ribbon Health as an investor. |